Efficacy and prognosis of transurethral holmium laser en-blocresection of bladder tumor in the treatment of non-invasive bladder cancer
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 6
Abstract
Objective To investigate the efficacy and prognosis of transurethral holmium laser en-bloc resection of bladder tumor (HOLRBT) and transurethral resection of bladder tumor (TURBT) in the treatment of non-invasive bladder cancer. Methods Eighty-six patients with non-invasive bladder cancer treated in the Third Affiliated Hospital of Anhui Medical University from January 2019 to May 2021 were selected as the study subjects. According to the random number table method, they were divided into the observation group (treated with HOLRBT) and the control group (treated with TURBT), with 43 patients in each group. The following indexes were compared, including operation time, hospital stay, bleeding volume, bladder irrigation time, urinary catheter retention time, peripheral blood lymphocyte subsets（CD4+, CD8+, CD4+/CD8+）, serum micro-RNA-119a (miR-119a), cytokeratin fragment antigen (CYFRA21-1), urine nuclear matrix protein 22 (NMP-22) levels, as well as the complications rates, recurrence rates and survival time. Results There was no statistically significant difference in operation time, hospital stay, and complication incidence between the two groups (P＞0.05). The bleeding volume, bladder irrigation time, and urinary catheter retention time in the observation group were shorter than those in the control group (P＜0.05). There was no statistically significant difference in preoperative CD4+, CD8+, CD4+/CD8+, miR-119a, CYFRA21-A and NMP-22 (P＞0.05). Three days after surgery, levels of CD4+ and CD4+/CD8+ in the observation group were higher than those in the control group, while levels of CD8+, miR-119a, CYFRA21-A, and NMP-22 were lower than those in the control group (P＜0.05). During the follow-up to June 2023, the 1-year and 2-year postoperative recurrence rates in the observation group were lower than those in the control group, while the progression-free survival time was longer than that in the control group (P＜0.05). Conclusion HOLRBT has an ideal effect in the treatment of non-invasive bladder cancer, which is conducive to prolonging the postoperative progression-free survival time and reducing the recurrence rate of patients.
Authors and Affiliations
SUN Cheng, ZHANG Chao, LI Qinghua, WANG Yu, WEN Zhu, YANG Shuai
Keywords
Related Articles
- EP ID EP738421
- DOI 10.13429/j.cnki.cjcr.2024.06.018
- Views 47
- Downloads 0
Advances in the application of echocardiography in septic cardiomyopathy
Septic cardiomyopathy (SCM) is an acute heart dysfunction caused by sepsis. Literature reports its incidence fluctuating between 13.8% and 60.0%, with a high mortality rate of 70% to 90%. Currently, there is no gold stan...
Effects of laparoscopic surgery combined with hyperthermic intraperitoneal chemotherapy on postoperative coagulation indicators in patients with colorectal cancer
Objective To observe the changes of coagulation function in patients with colorectal cancer (CRC) after laparoscopic surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC). Methods Sixty patients with CR...
Clinical application and research progress of lymphovascular markers for breast cancer
Breast cancer has become the most common malignant tumor in women, and its diagnosis and treatment principles mainly depend on the traditional histological and molecular pathological features. However, the systemic metas...
Evaluation of plasma atherogenic index on short-term prognosis of intravascular interventional therapy in patients with acute ischemic stroke
Objective To explore the role of plasma atherosclerotic index (AIP) in evaluating the short-term prognosis of endovascular intervention in acute ischemic stroke (AIS) patients of different age groups. Methods From Janu...
Surgical treatment of secondary hyperparathyroidism in patients with chronic renal failure
Secondary hyperparathyroidism (SHPT), as a common complication of chronic renal failure, has always been a focus of clinical research on the treatment of parathyroidism. The pathogenesis of SHPT is due to the abnormal se...